Hospital Corporation of Utah

Hospital Corporation of Utah was paid $6.04M by Medicaid between Jan 2018 and Oct 2024, across 83 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 70% of everything it billed.

33Billing provider infoHOSPITAL CORPORATION OF UTAH
BOUNTIFUL, UT 84010

33aNPI1528010451assigned 05/17/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$6.04M

24GClaims118,964

24DCodes billed83

24AFirst – last monthJan 2018 – Oct 2024

Compared with peers

Next to other General Acute Care Hospital providers in Utah

Rank by total paid#15 of 26

Median peer was paid$6.14M

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	20,099	$800K
2019	23,362	$943K
2020	20,602	$1.15M
2021	27,625	$1.56M
2022	25,707	$1.50M
2023	1,456	$71K
2024incomplete	113	$6K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
8888888	Internal/system code - not a standard HCPCS code	70%	14,613	6,410	$4.22M
80053	Comprehensive metabolic panel	7.9%	7,290	5,682	$474K
36415	Collection of venous blood by venipuncture	5.4%	4,009	3,134	$327K
96361	Intravenous infusion, hydration; each additional hour	2.1%	713	605	$128K
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.1%	4,745	3,886	$125K
80048	Basic metabolic panel (calcium, ionized)	1.2%	2,677	1,466	$74K
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	1.1%	7,223	5,699	$69K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.1%	1,145	961	$68K
80047		1.1%	755	600	$67K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	1,946	1,342	$54K
70450	Computed tomography, head or brain; without contrast material	<1%	1,132	910	$43K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	1,032	911	$42K

71 more codes

96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	5,508	$39K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,422	$35K
81001		<1%	5,801	$26K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,159	$22K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	531	$17K
71045	Radiologic examination, chest; single view	<1%	1,778	$17K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	1,592	$17K
71046	Radiologic examination, chest; 2 views	<1%	894	$16K
99285	Emergency room visit (most serious)	<1%	1,537	$16K
J3490	Unclassified drugs	<1%	47	$14K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	470	$14K
87400		<1%	212	$12K
87086	Culture, bacterial; quantitative colony count, urine	<1%	1,326	$10K
85027		<1%	10,934	$10K
80306		<1%	1,314	$8K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	56	$8K
G0378	Hospital observation service, per hour	<1%	64	$6K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	2,930	$6K
84703		<1%	1,181	$5K
84484		<1%	2,193	$4K
96375	Therapeutic injection; each additional sequential IV push	<1%	2,532	$4K
81025		<1%	819	$4K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	2,386	$4K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	2,028	$3K
J7030	Infusion, normal saline solution , 1000 cc	<1%	3,896	$3K
83690		<1%	2,937	$3K
80076		<1%	538	$2K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	930	$2K
83605		<1%	1,695	$2K
87070		<1%	214	$2K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	289	$2K
87420		<1%	35	$1K
76830	Ultrasound, transvaginal	<1%	27	$1K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	15	$1K
85379		<1%	315	$1K
96376		<1%	298	$881.32
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	201	$876.45
J7050	Infusion, normal saline solution, 250 cc	<1%	1,692	$738.29
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	2,334	$725.49
84443	Thyroid stimulating hormone (TSH)	<1%	1,718	$709.84
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	91	$651.62
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	61	$612.81
87186		<1%	1,105	$604.61
73562		<1%	13	$555.28
87040		<1%	249	$502.22
85610		<1%	512	$492.87
J1170	Injection, hydromorphone, up to 4 mg	<1%	725	$449.50
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	66	$447.52
71275	Computed tomographic angiography, chest, with contrast material	<1%	153	$165.80
86140		<1%	51	$123.31
87088		<1%	13	$122.43
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	15	$109.32
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	42	$86.82
83880		<1%	309	$67.86
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	72	$19.22
87634		<1%	99	$15.07
J2550	Injection, promethazine hcl, up to 50 mg	<1%	148	$13.14
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	247	$10.20
80143		<1%	356	$8.21
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	85	$3.12
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	556	$1.15
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	26	$0.43
J7120	Ringers lactate infusion, up to 1000 cc	0%	256	$0.00
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	134	$0.00
80061	Lipid panel	0%	45	$0.00
84439		0%	20	$0.00
J2060	Injection, lorazepam, 2 mg	0%	228	$0.00
82550		0%	16	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	63	$0.00
85652		0%	64	$0.00
83036	Hemoglobin; glycosylated (A1C)	0%	16	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDALTON, WAYNE (CFO)